Literature DB >> 23218993

Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants.

T N Hoa Tran1, Eamonn Trainor, Toyoko Nakagomi, Nigel A Cunliffe, Osamu Nakagomi.   

Abstract

Noroviruses are a leading cause of epidemic and sporadic acute gastroenteritis worldwide. The development of sensitive molecular diagnostic techniques has revolutionized our understanding of norovirus epidemiology over the past two decades, but norovirus strain types associated with sporadic gastroenteritis remain poorly described. Therefore, we conducted a systematic review of studies performed after 2000 to clarify the genotypic distribution of noroviruses in children (≤18 years of age) with sporadic acute gastroenteritis. Genogroup GII norovirus was the most prevalent, accounting for 96% of all sporadic infections. GII.4 was the most prevalent genotype, accounting for 70% of the capsid genotypes and 60% of the polymerase genotypes, followed by the capsid genotype GII.3 (16%) and the polymerase genotype GII.b (14%). The most common ORF1/ORF2 inter-genotype recombinants were GII.b, GII.12, and GII.4 polymerase genotypes combined with the capsid genotype GII.3, accounting for 19% of all genotyped strains. The distribution of GII.4 variants over the last decade was dominated by successive circulation of GII.4/2002, GII.4/2004, GII.4/2006b, and GII.4/2008 with GII.4/2006b continuing to date. Genotypes GII.4 and GII.3 have predominated in children during the past decade; this is most notable in the global emergence of GII.4 variant noroviruses. As the burden of rotavirus disease decreases following the introduction of childhood immunization programs, the relative importance of norovirus in the etiology of acute childhood gastroenteritis will likely increase. In order for a successful norovirus vaccine to be developed, it should provide immunity against strains with capsid genotypes GII.4 and GII.3.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218993     DOI: 10.1016/j.jcv.2012.11.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  116 in total

1.  Environmental Surveillance for Noroviruses in Selected South African Wastewaters 2015-2016: Emergence of the Novel GII.17.

Authors:  V V Mabasa; K D Meno; M B Taylor; Janet Mans
Journal:  Food Environ Virol       Date:  2017-08-04       Impact factor: 2.778

Review 2.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

3.  Norovirus strains in patients with acute gastroenteritis in rural and low-income urban areas in northern Brazil.

Authors:  Rory J Tinker; Antonio Charlys da Costa; Roozbeh Tahmasebi; Eric Delwart; Ester Cerdeira Sabino; Elcio Leal; Adriana Luchs; Flavio Augusto de Pádua Milagres; Vanessa Dos Santos Morais; Ramendra Pati Pandey; Alexis José-Abrego; Rafael Brustulin; Maria da Aparecida Rodrigues Teles; Mariana Sequetin Cunha; Emerson Luiz Lima Araújo; Mariela Martínez Gómez; Xutao Deng
Journal:  Arch Virol       Date:  2021-01-19       Impact factor: 2.574

4.  Immune-Focusing Properties of Virus-like Particles Improve Protective IgA Responses.

Authors:  Taishi Onodera; Kana Hashi; Rajni Kant Shukla; Motohiro Miki; Reiko Takai-Todaka; Akira Fujimoto; Masayuki Kuraoka; Tatsuya Miyoshi; Kazuo Kobayashi; Hideki Hasegawa; Manabu Ato; Garnett Kelsoe; Kazuhiko Katayama; Yoshimasa Takahashi
Journal:  J Immunol       Date:  2019-11-08       Impact factor: 5.422

5.  Evaluation of a Porcine Gastric Mucin and RNase A Assay for the Discrimination of Infectious and Non-infectious GI.1 and GII.4 Norovirus Following Thermal, Ethanol, or Levulinic Acid Plus Sodium Dodecyl Sulfate Treatments.

Authors:  Olamide T Afolayan; Cathy C Webb; Jennifer L Cannon
Journal:  Food Environ Virol       Date:  2015-10-29       Impact factor: 2.778

6.  Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.

Authors:  Wen Dang; Yuebang Yin; Yijin Wang; Wenshi Wang; Junhong Su; Dave Sprengers; Luc J W van der Laan; Krzysztof Felczak; Krzysztof W Pankiewicz; Kyeong-Ok Chang; Marion P G Koopmans; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.

Authors:  Robert L Atmar; Frank Baehner; Jakob P Cramer; Eric Song; Astrid Borkowski; Paul M Mendelman
Journal:  J Infect Dis       Date:  2016-06-28       Impact factor: 5.226

8.  Genetic Diversity Among Genogroup II Noroviruses and Progressive Emergence of GII.17 in Wastewaters in Italy (2011-2016) Revealed by Next-Generation and Sanger Sequencing.

Authors:  E Suffredini; M Iaconelli; M Equestre; B Valdazo-González; A R Ciccaglione; C Marcantonio; S Della Libera; F Bignami; G La Rosa
Journal:  Food Environ Virol       Date:  2017-11-28       Impact factor: 2.778

9.  Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients.

Authors:  Ying-Chun Dai; Ming Xia; Qiong Huang; Ming Tan; Lin Qin; Ya-Li Zhuang; Yan Long; Jian-Dong Li; Xi Jiang; Xu-Fu Zhang
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

Review 10.  Epidemiology of human noroviruses and updates on vaccine development.

Authors:  Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.